IMMX
Price
$1.58
Change
-$0.04 (-2.47%)
Updated
Nov 15, 03:24 PM (EDT)
12 days until earnings call
SRZN
Price
$8.78
Change
-$0.70 (-7.38%)
Updated
Nov 15, 02:56 PM (EDT)
Ad is loading...

IMMX vs SRZN

Header iconIMMX vs SRZN Comparison
Open Charts IMMX vs SRZNBanner chart's image
Immix Biopharma
Price$1.58
Change-$0.04 (-2.47%)
Volume$100
CapitalizationN/A
Surrozen
Price$8.78
Change-$0.70 (-7.38%)
Volume$1.08K
CapitalizationN/A
IMMX vs SRZN Comparison Chart
Loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
IMMX vs. SRZN commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and SRZN is a Hold.

COMPARISON
Comparison
Nov 15, 2024
Stock price -- (IMMX: $1.62 vs. SRZN: $9.48)
Brand notoriety: IMMX and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 32% vs. SRZN: 19%
Market capitalization -- IMMX: $44.47M vs. SRZN: $30.81M
IMMX [@Biotechnology] is valued at $44.47M. SRZN’s [@Biotechnology] market capitalization is $30.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $475.76B to $0. The average market capitalization across the [@Biotechnology] industry is $2.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMMX and SRZN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 3 TA indicator(s) are bullish.

  • IMMX’s TA Score: 3 bullish, 4 bearish.

Price Growth

IMMX (@Biotechnology) experienced а -7.43% price change this week, while SRZN (@Biotechnology) price change was -6.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.92%. For the same industry, the average monthly price growth was -3.17%, and the average quarterly price growth was +1.57%.

Reported Earning Dates

IMMX is expected to report earnings on Feb 26, 2025.

SRZN is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (-5.92% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMX($44.5M) has a higher market cap than SRZN($30.8M). SRZN YTD gains are higher at: 0.850 vs. IMMX (-76.590).
IMMXSRZNIMMX / SRZN
Capitalization44.5M30.8M144%
EBITDAN/AN/A-
Gain YTD-76.5900.850-9,010%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/A2.79M-
TECHNICAL ANALYSIS
Technical Analysis
IMMX
RSI
ODDS (%)
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
0%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
View a ticker or compare two or three
Ad is loading...
IMMX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and PLRX have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and PLRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+3.18%
PLRX - IMMX
23%
Poorly correlated
-6.68%
WINT - IMMX
23%
Poorly correlated
-6.25%
OBIO - IMMX
23%
Poorly correlated
+2.31%
SRZN - IMMX
23%
Poorly correlated
+3.04%
VALN - IMMX
22%
Poorly correlated
-0.20%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with ALRN. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then ALRN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+3.04%
ALRN - SRZN
44%
Loosely correlated
-7.28%
INAB - SRZN
39%
Loosely correlated
+6.09%
KMSTF - SRZN
34%
Loosely correlated
N/A
IRON - SRZN
30%
Poorly correlated
-3.79%
IKNA - SRZN
26%
Poorly correlated
-1.72%
More